359 related articles for article (PubMed ID: 11170858)
21. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
[TBL] [Abstract][Full Text] [Related]
22. Improving animal and human health through understanding liver fluke immunology.
Piedrafita D; Spithill TW; Smith RE; Raadsma HW
Parasite Immunol; 2010 Aug; 32(8):572-81. PubMed ID: 20626812
[TBL] [Abstract][Full Text] [Related]
23. Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.
Buffoni L; Garza-Cuartero L; Pérez-Caballero R; Zafra R; Javier Martínez-Moreno F; Molina-Hernández V; Pérez J; Martínez-Moreno Á; Mulcahy G
Parasit Vectors; 2020 Jul; 13(1):390. PubMed ID: 32736582
[TBL] [Abstract][Full Text] [Related]
24. Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1).
Kesik M; Jedlina-Panasiuk L; Kozak-Cieszczyk M; Płucienniczak A; Wedrychowicz H
Vaccine; 2007 May; 25(18):3619-28. PubMed ID: 17289224
[TBL] [Abstract][Full Text] [Related]
25. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
[TBL] [Abstract][Full Text] [Related]
26. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
[TBL] [Abstract][Full Text] [Related]
27. Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library.
Villa-Mancera A; Quiroz-Romero H; Correa D; Ibarra F; Reyes-Pérez M; Reyes-Vivas H; López-Velázquez G; Gazarian K; Gazarian T; Alonso RA
Parasitology; 2008 Oct; 135(12):1437-45. PubMed ID: 18812010
[TBL] [Abstract][Full Text] [Related]
28. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
[TBL] [Abstract][Full Text] [Related]
29. [The immune response of various species to Fasciola hepatica infection].
Jedlina-Panasiuk L
Wiad Parazytol; 2002; 48(1):11-21. PubMed ID: 16883699
[TBL] [Abstract][Full Text] [Related]
30. Chemoprophylaxis with diamfenetide against experimental infections of Fasciola hepatica in ruminants.
Enzie FD; Rew RS; Colglazier ML
Am J Vet Res; 1980 Feb; 41(2):179-82. PubMed ID: 7369590
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle.
Estuningsih SE; Smooker PM; Wiedosari E; Widjajanti S; Vaiano S; Partoutomo S; Spithill TW
Int J Parasitol; 1997 Nov; 27(11):1419-28. PubMed ID: 9421734
[TBL] [Abstract][Full Text] [Related]
32. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
[TBL] [Abstract][Full Text] [Related]
33. Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity.
Wijffels GL; Salvatore L; Dosen M; Waddington J; Wilson L; Thompson C; Campbell N; Sexton J; Wicker J; Bowen F
Exp Parasitol; 1994 Mar; 78(2):132-48. PubMed ID: 8119370
[TBL] [Abstract][Full Text] [Related]
34. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
[TBL] [Abstract][Full Text] [Related]
35. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica.
Mulcahy G; O'Connor F; McGonigle S; Dowd A; Clery DG; Andrews SJ; Dalton JP
Vaccine; 1998; 16(9-10):932-9. PubMed ID: 9682340
[TBL] [Abstract][Full Text] [Related]
36. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
[TBL] [Abstract][Full Text] [Related]
37. Immunological approaches for the control of fasciolosis.
Spithill TW; Piedrafita D; Smooker PM
Int J Parasitol; 1997 Oct; 27(10):1221-35. PubMed ID: 9394193
[TBL] [Abstract][Full Text] [Related]
38. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
Phiri IK; Phiri AM; Harrison LJ
Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings.
Timoteo O; Maco V; Maco V; Neyra V; Yi PJ; Leguía G; Espinoza JR
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):77-86. PubMed ID: 15910994
[TBL] [Abstract][Full Text] [Related]
40. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis.
Acosta D; Cancela M; Piacenza L; Roche L; Carmona C; Tort JF
Mol Biochem Parasitol; 2008 Mar; 158(1):52-64. PubMed ID: 18178266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
